Triple-negative breast cancer (TNBC) is defined as breast cancer in which estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) are all negative [4]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.